EHMT2 and adenocarcinoma: To determine the role of EHMT1 and EHMT2 in prostate cancer progression, we examined their protein levels in adenocarcinoma prostate cancer lines (LNCaP, 22Rv1) and stem cell or neuroendocrine (NE)-like prostate cancer lines (PC-3, NCI-H660).